Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page version has been updated from v3.0.1 to v3.0.2. The non-critical 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:48:54.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T07:29:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as various types of antibodies and proteins. However, many specific medical terms and diseases have been removed, indicating a shift in focus.
    Difference
    5%
    Check dated 2025-08-31T00:47:21.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T17:49:28.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T14:42:35.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page has been updated to include a new HHS Vulnerability Disclosure and has been revised to version 2.16.10, replacing the previous version 2.16.6. Additionally, a service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T12:40:27.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.